ABPA in adulthood: A CFTR-related disorder

Thorax

Volumn 66, Issue 6, 2011, Pages 540-541

  Lebecque, Patrick ^a   Pepermans, X ^a   Marchand, E ^b   Leonard, A ^a   Leal, T ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGED; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DNA DETERMINATION; EXON; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; INTRON; LETTER; MALE; PATHOGENESIS; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SWEAT TEST;

EID: 79956351979     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.145862     Document Type: Letter

References (5)

1. Miller PW, Hamosh A, Macek M, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996;59:45-51. (Pubitemid 26189727)
2. Marchand E, Verellen-Dumoulin C, Mairesse M, et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001;119:762-7. (Pubitemid 32197645)
3. Eaton TE, Weiner Miller P, Garrett JE, et al. Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the aetiology of allergic bronchopulmonary aspergillosis? Clin Exp Allergy 2002;32:756-61.
4. Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008;153:S4-14.
5. Castellani C, Cuppens H, Macek M Jr, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008;7:179-96.